NCT01736241View on ClinicalTrials.gov

A Study of LY3053102 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

LY3053102

DRUG

Placebo

Trial Locations (1)

117597

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01736241 - A Study of LY3053102 in Healthy Participants | Biotech Hunter | Biotech Hunter